Literature DB >> 14734607

Accumulation of Valpha7.2-Jalpha33 invariant T cells in human autoimmune inflammatory lesions in the nervous system.

Zsolt Illés1, Michio Shimamura, Jia Newcombe, Nobuyuki Oka, Takashi Yamamura.   

Abstract

T cells expressing an invariant TCR alpha chain and NK cell markers are expected to exhibit unique functions. Whereas much attention has been paid to CD1d-restricted NKT cells, a second NKT cell population bearing an invariant AV19-AJ33 TCR has recently been identified in mice and humans. Selection and/or expansion of this population require B cells, and would involve a non-classical class I-related molecule MR1. Although their preferential distribution in the gut mucosa indicates their role in the host response at the site of pathogen entry, it remains unknown whether they play an alternative role at different sites or in immunological disorders. Using single-strand conformation polymorphism clonotype analysis, we investigated the presence of the human AV19-AJ33 T cells (V(alpha)7.2-J(alpha)33 T cells) in autopsy samples from multiple sclerosis (MS) patients as well as in nerve biopsy samples from chronic inflammatory demyelinating polyneuropathy (CIDP) patients. Here we report that the V(alpha)7.2-J(alpha)33 T cells are accumulated in some of the central nervous system lesions of MS and in the majority of the peripheral nerve samples from CIDP. We have previously revealed that CD1d-restricted, V(alpha)24-J(alpha)Q NKT cells are remarkably reduced in the peripheral blood from MS. However, V(alpha)7.2-J(alpha)33 T cells are not reduced in the peripheral blood from MS and could be detected in a large majority of the cerebrospinal fluid samples obtained during relapse of MS. The present results indicate that the V(alpha)7.2-J(alpha)33 T cells are involved in the autoimmune inflammatory lesions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734607     DOI: 10.1093/intimm/dxh018

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  50 in total

1.  Fighting infection with your MAITs.

Authors:  Dale I Godfrey; Jamie Rossjohn; James McCluskey
Journal:  Nat Immunol       Date:  2010-08       Impact factor: 25.606

2.  Pathogenesis and treatment of immune-mediated neuropathies.

Authors:  Helmar C Lehmann; Gerd Meyer Zu Horste; Bernd C Kieseier; Hans-Peter Hartung
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

Review 3.  The role of natural killer cells in curbing neuroinflammation.

Authors:  Benjamin M Segal
Journal:  J Neuroimmunol       Date:  2007-09-29       Impact factor: 3.478

Review 4.  The role of mucosal-associated invariant T cells in infectious diseases.

Authors:  Emily B Wong; Thumbi Ndung'u; Victoria O Kasprowicz
Journal:  Immunology       Date:  2016-10-26       Impact factor: 7.397

5.  Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation.

Authors:  Cecilie Ammitzbøll; Lars Börnsen; Eva Rosa Petersen; Annette Bang Oturai; Helle Bach Søndergaard; Philippe Grandjean; Finn Sellebjerg
Journal:  J Neuroimmunol       Date:  2019-03-02       Impact factor: 3.478

Review 6.  Check MAIT.

Authors:  Laurent Gapin
Journal:  J Immunol       Date:  2014-05-15       Impact factor: 5.422

7.  The molecular basis for Mucosal-Associated Invariant T cell recognition of MR1 proteins.

Authors:  Jacinto López-Sagaseta; Charles L Dulberger; James E Crooks; Chelsea D Parks; Adrienne M Luoma; Amanda McFedries; Ildiko Van Rhijn; Alan Saghatelian; Erin J Adams
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-23       Impact factor: 11.205

8.  Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis.

Authors:  Sofia V Abrahamsson; Daniela F Angelini; Amy N Dubinsky; Esther Morel; Unsong Oh; Joanne L Jones; Daniele Carassiti; Richard Reynolds; Marco Salvetti; Peter A Calabresi; Alasdair J Coles; Luca Battistini; Roland Martin; Richard K Burt; Paolo A Muraro
Journal:  Brain       Date:  2013-07-17       Impact factor: 13.501

Review 9.  [The significance of intravenous immunoglobulin in treatment of immune-mediated polyneuropathies].

Authors:  M Stangel; H-P Hartung; R Gold; B C Kieseier
Journal:  Nervenarzt       Date:  2009-06       Impact factor: 1.214

Review 10.  Where do MAIT cells fit in the family of unconventional T cells?

Authors:  Laurent Gapin
Journal:  PLoS Biol       Date:  2009-03-31       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.